IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

VIGANO', OTTAVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.799
EU - Europa 1.384
AS - Asia 1.195
SA - Sud America 187
AF - Africa 38
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 4.613
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.723
GB - Regno Unito 377
SG - Singapore 374
CN - Cina 347
IT - Italia 252
DE - Germania 174
BR - Brasile 146
SE - Svezia 145
RU - Federazione Russa 98
HK - Hong Kong 94
BD - Bangladesh 83
FR - Francia 70
CA - Canada 64
VN - Vietnam 63
NL - Olanda 62
IN - India 53
UA - Ucraina 50
TR - Turchia 46
FI - Finlandia 42
IE - Irlanda 38
KR - Corea 34
EU - Europa 26
JP - Giappone 23
ID - Indonesia 21
BE - Belgio 19
CI - Costa d'Avorio 15
CO - Colombia 13
GR - Grecia 10
ZA - Sudafrica 8
AR - Argentina 7
DK - Danimarca 7
ES - Italia 7
PL - Polonia 7
VE - Venezuela 7
AT - Austria 6
AU - Australia 6
CL - Cile 5
MX - Messico 5
TH - Thailandia 5
IL - Israele 4
IQ - Iraq 4
JO - Giordania 4
MA - Marocco 4
PK - Pakistan 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
OM - Oman 3
PH - Filippine 3
PS - Palestinian Territory 3
RO - Romania 3
UY - Uruguay 3
AM - Armenia 2
BG - Bulgaria 2
CH - Svizzera 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
EG - Egitto 2
IR - Iran 2
KE - Kenya 2
KH - Cambogia 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
LU - Lussemburgo 2
PE - Perù 2
PY - Paraguay 2
SA - Arabia Saudita 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
CM - Camerun 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EC - Ecuador 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GT - Guatemala 1
KG - Kirghizistan 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MT - Malta 1
MU - Mauritius 1
MW - Malawi 1
NC - Nuova Caledonia 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
UG - Uganda 1
Totale 4.637
Salva come PNG Salva come JPEG
Città #
Southend 326
Ashburn 220
Singapore 219
Chandler 144
San Jose 87
Hong Kong 84
Milan 80
Fairfield 79
Beijing 73
Ann Arbor 67
Dallas 65
Woodbridge 62
Council Bluffs 57
Seattle 56
Santa Clara 53
Wilmington 50
Houston 48
Princeton 43
Los Angeles 42
Dearborn 38
Dublin 38
New York 32
Toronto 31
Cambridge 28
Jacksonville 28
Boardman 26
Munich 26
Frankfurt am Main 24
Redmond 24
Buffalo 22
Ho Chi Minh City 22
Brussels 19
Helsinki 19
Montreal 19
Tokyo 19
Jakarta 18
Lauterbourg 18
Hefei 17
Bengaluru 16
Nanjing 16
Somerville 16
Rome 15
São Paulo 15
Mountain View 14
Phoenix 14
Sakarya 14
Shanghai 14
Columbus 13
Abidjan 12
Guangzhou 12
Hanoi 12
Andover 11
Bogotá 11
Cangzhou 11
Des Moines 11
Moscow 11
The Dalles 11
Tianjin 11
Turin 11
Athens 10
Redwood City 10
Seoul 10
Florence 9
Grafing 8
Kent 8
Orem 8
Serra 8
Atlanta 7
Cagliari 7
Jinan 7
Naples 7
Warsaw 7
Hebei 6
Margão 6
Nürnberg 6
Padova 6
Porto Alegre 6
Silver Spring 6
Belo Horizonte 5
Changsha 5
Chicago 5
London 5
Mumbai 5
Nanchang 5
Quanzhou 5
San Diego 5
San Francisco 5
Shenyang 5
Turku 5
Wuhan 5
Yubileyny 5
Amman 4
Berlin 4
Boston 4
Eitensheim 4
Fuzhou 4
Haiphong 4
Istanbul 4
Johannesburg 4
McAllen 4
Totale 2.837
Salva come PNG Salva come JPEG
Nome #
Evolution of the HIV-1 protease region in heavily pretreated HIV-1 infected patients receiving Atazanavir 336
Comparative evaluation of seven resistance interpretation algorithms and their derived genotypic inhibitory quotients for the prediction of 48 week virological response to darunavir-based salvage regimens 331
Does GSS Still Maintain Relevance on HAART Outcome After the Introduction of Newest Active Antiretroviral Drugs? 48 Weeks Results 313
Analysis of protease inhibitor combinations in vitro : activity of lopinavir, amprenavir and tipranavir against HIV type 1 wild-type and drug-resistant isolates 290
Abacavir hypersensitivity reaction after switching from the twice-daily to the once-daily formulation 289
Efficacy and safety of a dual boosted protease inhibitor-based regimen, atazanavir and fosamprenavir/ritonavir, against HIV : experience in a pediatric population 289
New macrocyclic amines showing activity as HIV entry inhibitors against wild type and multi-drug resistant viruses 272
Efficacia di Caspofungin nella candidosi esofagea HIV-correlata multifarmacoresistente 257
Unusual codon 69 insertions : influence on human immunodeficiency virus type 1 reverse transcriptase drug susceptibility 244
Absence of new thymidine-associated mutations and evidence of an immune virologic response over a 12-month period in a cohort of antiretroviral- experienced HIV-1-infected subjects treated with tenofovir combination therapy [2] 238
Predictive factors of therapeutic success of a HAART regimen including atazanavir with or without ritonavir in HIV-infected patients 223
Successful rescue therapy with Raltegravir (MK-0518) and Etravirine (TMC125) in an HIV-infected patient failing all four classes of antiretroviral drugs 209
Female gender is associated with long COVID syndrome : a prospective cohort study 203
Switching to unboosted atazanavir reduces bilirubin and triglycerides without compromising treatmentefficacy in UGT1A1*28 polymorphism carriers 201
Real World Estimate of Vaccination Protection in Individuals Hospitalized for COVID-19 195
Successful pharmacogenetics-based optimization of unboosted atazanavir plasma exposure in HIV-positive patients : a randomized, controlled, pilot study (the REYAGEN study) 170
Efficacy, tolerability and virological consequences of long-term use of unboosted atazanavir plus 2 NRTIs in HIV-infected patients 168
New HIV protease inhibitors for drug-resistant viruses 153
Three case reports of West Nile virus neuroinvasive disease: lessons from real-life clinical practice 146
Haemoptysis and fever in a young refugee from Somalia 144
Resolution of multidrug-refractory oesophageal candidiasis in an AIDS patient after treatment with caspofungin 136
null 3
Totale 4.810
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.270
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.270
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202121 0 0 0 0 0 0 0 0 0 0 0 21
2021/2022265 33 9 11 9 14 11 20 22 50 26 11 49
2022/2023409 41 46 39 53 33 86 6 33 51 2 15 4
2023/2024232 13 20 16 29 38 13 17 14 3 11 19 39
2024/2025750 18 54 12 93 70 36 67 58 52 73 70 147
2025/20261.472 161 126 144 96 113 80 171 51 134 124 228 44
Totale 4.810